Evidence map›Paper›PMID 37073134›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2023

Decellularization of the human urethra for tissue engineering applications.

Marcela Kuniakova, Martin Klein, Paulina Galfiova, Maria Csobonyeiova, Claudia Feitscherova, Stefan Polak, Zuzana Varchulova Novakova, Katarina Topoliova, Branislav Trebaticky, Ivan Varga and 2 more

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Tissue Engineering for Penile Reconstruction.Bioengineering (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Marcela KuniakovaInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava 811 08, Slovakia.
Martin KleinNational Institute of Rheumatic Diseases, Piestany 921 12, Slovakia.
Paulina GalfiovaInstitute of Histology and Embryology, Faculty of Medicine, Comenius University Bratislava, Bratislava 811 08, Slovakia.
Maria CsobonyeiovaNational Institute of Rheumatic Diseases, Piestany 921 12, Slovakia.
Claudia FeitscherovaNational Institute of Rheumatic Diseases, Piestany 921 12, Slovakia.
Stefan PolakInstitute of Histology and Embryology, Faculty of Medicine, Comenius University Bratislava, Bratislava 811 08, Slovakia.
Zuzana Varchulova NovakovaInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava 811 08, Slovakia.
Katarina TopoliovaDepartment of Urology, Faculty of Medicine, Comenius University Bratislava, Bratislava 833 05, Slovakia.
Branislav TrebatickyNational Institute of Rheumatic Diseases, Piestany 921 12, Slovakia.
Ivan VargaNational Institute of Rheumatic Diseases, Piestany 921 12, Slovakia.ORCID 0000-0002-0918-741X
Lubos DanisovicInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava 811 08, Slovakia.ORCID 0000-0002-5074-9621
Stanislav ZiaranNational Institute of Rheumatic Diseases, Piestany 921 12, Slovakia.
National Institute of Rheumatic Diseases · SKComenius University Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, several scaffolds have been introduced for urethral tissue engineering. However, acellular human urethral scaffold harvested from deceased donors may provide significant advantages compared to synthetic, composite, or other biological scaffolds. This study aims to develop the protocol for decellularization of the human urethra that preserves substantial extracellular matrix (ECM) components, which are essential for subsequent recellularization mimicking the natural environment of the native ECM. A total of 12 human urethras were harvested from deceased donors. An equal part of every harvested urethra was used as a control sample for analyses. The protocol design was based on the enzyme-detergent-enzyme method. Trypsin and Triton X-100 were used to remove cells, followed by DNase treatment to remove DNA residues. Subsequently, the specimens were continually rinsed in deionized water for seven days. The efficiency of decellularization was determined by histochemistry, immunohistochemical staining, scanning electron microscopy (SEM), and DNA quantification. Histological analysis confirmed cell removal and preservation of urethral structure after decellularization. The preservation of collagen IV and fibronectin was confirmed by histologic examination and immunohistochemical staining. SEM confirmed the maintenance of the ultrastructural architecture of ECM and fibers. DNA content in decellularized urethra was significantly lower compared to the native sample (

Indexed as

Tissue EngineeringUrethraDetergentsDNAExtracellular MatrixHumansTissue ScaffoldsDetergentsDNAdecellularizationscaffoldtissue engineeringUrethra

Identifiers

PMID37073134
PMCPMC10581165
OpenAlexW4366351573

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.